Literature DB >> 14605880

Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids.

Mine Genç1, Natasja Castro Kreder, Angelique Barten-van Rijbroek, Lukas J A Stalpers, Jaap Haveman.   

Abstract

BACKGROUND AND
PURPOSE: To determine the cytotoxicity of, and radioenhancement by, gemcitabine on a glioma cell line grown as a monolayer and as spheroid cultures.
MATERIAL AND METHODS: We used a human glioma cell line, Gli-6, which originated from a biopsy specimen of a patient with a glioblastoma multiforme. Spheroids of Gli-6 were prepared by seeding a single cell suspension on agarose-coated Petri dishes. Clonogenic and growth delay assays were used to determine radio-chemosensitivity of monolayer cultures. The growth delay assay was used to determine that of Gli-6 spheroid cultures.
RESULTS: Spheroid cultures were found to be more resistant to irradiation with/or without gemcitabine than monolayer cultures. Whereas gemcitabine significantly enhances the radiation effect of exponentially growing Gli-6 monolayer cultures at minimal cytotoxic concentrations (10 nM, 24 h), no enhancement was seen in confluent monolayer cultures and in large spheroids at the same concentration. In small spheroids no enhancement was observed at a low-dose gemcitabine (10 nM for 24 h), but an enhancement was observed at higher concentrations (100 nM for 24 h).
CONCLUSION: Gemcitabine can lead to enhancement of the effects of X-irradiation in both monolayer as spheroid glioblastoma cultures. The lack of enhancement in confluent monolayer cultures supports the view that cell cycle distribution of cells is important in radiosensitisation by gemcitabine

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605880     DOI: 10.1007/s00432-003-0506-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Factors influencing the oxygen consumption and radiation response of cultured mammalian cells.

Authors:  J E Biaglow; M E Varnes; B Jacobson; C J Koch
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

3.  Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction.

Authors:  H Dertinger; D Hülser
Journal:  Radiat Environ Biophys       Date:  1981       Impact factor: 1.925

4.  Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.

Authors:  M Weller; J Streffer; W Wick; R D Kortmann; E Heiss; W Küker; R Meyermann; J Dichgans; M Bamberg
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

5.  NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

Authors:  S Z Gertler; D MacDonald; M Goodyear; P Forsyth; D J Stewart; K Belanger; J Perry; D Fulton; W Steward; N Wainman; L Seymour
Journal:  Ann Oncol       Date:  2000-03       Impact factor: 32.976

Review 6.  Multicellular tumour spheroids in radiation biology.

Authors:  M T Santini; G Rainaldi; P L Indovina
Journal:  Int J Radiat Biol       Date:  1999-07       Impact factor: 2.694

7.  Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

Authors:  A Taghian; J Ramsay; J Allalunis-Turner; W Budach; D Gioioso; F Pardo; P Okunieff; N Bleehen; R Urtasun; H Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-01-15       Impact factor: 7.038

8.  Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.

Authors:  D Latz; K Fleckenstein; M Eble; J Blatter; M Wannenmacher; K J Weber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

9.  Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

Authors:  Chris van Bree; Natasja Castro Kreder; Willem J P Loves; Nicolaas A P Franken; Godefridus J Peters; Jaap Haveman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas.

Authors:  P Kaaijk; D Troost; P K Das; S Leenstra; D A Bosch
Journal:  Neuropathol Appl Neurobiol       Date:  1995-10       Impact factor: 8.090

View more
  8 in total

1.  Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids.

Authors:  Hari R Kumar; Xiaoling Zhong; Derek J Hoelz; Frederick J Rescorla; Robert J Hickey; Linda H Malkas; John A Sandoval
Journal:  Pediatr Surg Int       Date:  2008-09-17       Impact factor: 1.827

2.  D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.

Authors:  S M El Sayed; R M Abou El-Magd; Y Shishido; K Yorita; S P Chung; D H Tran; T Sakai; H Watanabe; S Kagami; K Fukui
Journal:  J Bioenerg Biomembr       Date:  2012-07-17       Impact factor: 2.945

3.  Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy.

Authors:  Sylvine Cottin; Karim Ghani; Pedro Otavio de Campos-Lima; Manuel Caruso
Journal:  Mol Cancer       Date:  2010-06-10       Impact factor: 27.401

4.  Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.

Authors:  Isabelle Dufau; Céline Frongia; Flavie Sicard; Laure Dedieu; Pierre Cordelier; Frédéric Ausseil; Bernard Ducommun; Annie Valette
Journal:  BMC Cancer       Date:  2012-01-13       Impact factor: 4.430

5.  Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.

Authors:  Samuel L Collins; Rodolphe Hervé; C W Keevil; Jeremy P Blaydes; Jeremy S Webb
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

6.  The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.

Authors:  Bea Pauwels; Annelies E C Korst; Greet G O Pattyn; Hilde A J Lambrechts; Juliette A E Kamphuis; Christel M J De Pooter; Godefridus J Peters; Filip Lardon; Jan B Vermorken
Journal:  BMC Cancer       Date:  2006-05-30       Impact factor: 4.430

7.  Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy.

Authors:  Corinne Renier; John Do; Andrea Reyna-Neyra; Deshka Foster; Abhijit De; Hannes Vogel; Stefanie S Jeffrey; Victor Tse; Nancy Carrasco; Irene Wapnir
Journal:  Oncotarget       Date:  2016-08-23

8.  The micromass formation potential of human adipose-derived stromal cells isolated from different various origins.

Authors:  Benedikt Kleineidam; Sonja Sielker; Marcel Hanisch; Johannes Kleinheinz; Susanne Jung
Journal:  Head Face Med       Date:  2018-09-26       Impact factor: 2.151

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.